Columbia Laboratories Renews Agreement with Merck ... - Genetic Engineering News

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service18 times read : Adjust font size: Decrease font Enlarge font
image

Columbia Laboratories, Inc. (Nasdaq: CBRX ) has renewed its license and supply agreement with Merck Serono, a division of Merck KGaA, Darmstadt, Germany, for CRINONE ® (progesterone gel) for an additional five-year term. Under the existing agreement ...

Read this article...



Post your comment comment Comments (0 posted)

copyright